Marina Guirguis Hanna, MD
Urogynecology and Reconstructive Pelvic Surgery · Leesburg, VANPI 1912357559
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (41.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Axonics, Inc. at 33.7% of the total. Reporting peaked in 2023 at $1,824 and has fallen 92.9% since, to $129 in 2025.
Across 29 payments — averaging $152.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$1K
- Boston Scientific$1K
- Intuitive Surgical$1K
- Coloplast$318
- Caldera Medical, Inc$256
What the payments were for
- Travel & lodging$1,58936%
- Food & beverage$1,82541%
- Education$1,00023%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 14 | $1,488 |
| Boston Scientific | 8 | $1,294 |
| Intuitive Surgical | 3 | $1,058 |
| Coloplast | 2 | $318 |
| Caldera Medical, Inc | 2 | $256 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$1,024
- DAVINCI XI$1,000
- Bulkamid$559
- ALTIS$318
- Desara$256
How this compares
$4,414 in reported general payments places this provider in the 60th percentile of 29 urogynecology and reconstructive pelvic surgery providers in Virginia.
See all urogynecology and reconstructive pelvic surgery providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 96 | $67,688 |
| MyrbetriqMirabegron | 37 | $22,208 |
| Estradiol | 123 | $8,187 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 25 | $147 |
| Ibuprofen | 12 | $52 |
| Oxycodone Hcl | 18 | $31 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Leesburg
- Seyed ShobeiriFalls Church$116K
- Kurt McCammonVirginia Beach$67K
- Jeffrey WelgossAnnandale$50K
- Nathan GueretteMidlothian$20K
- Eric ChangStafford$11K
- Patricia MwesigwaArlington$8K
- Anna TrikhachevaPortsmouth$6K
- Walter von PechmannAnnandale$6K
- Mary BurnsViriginia Beach$6K
- Meghana GowdaRichmond$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.